Transdermal oxybutynin. A viewpoint by Adrian Wagg.
Wagg
A
A
Department of Geriatric Medicine, University College Hospital, London, England.
D000279:Administration, Cutaneous; D000328:Adult; D000368:Aged; D003692:Delayed-Action Preparations; D006801:Humans; D008333:Mandelic Acids / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D012867:Skin / Q000187:drug effects; D001745:Urinary Bladder Diseases / Q000188:drug therapy*; D014549:Urinary Incontinence / Q000188:drug therapy / Q000503:physiopathology
D003692:Delayed-Action Preparations; D008333:Mandelic Acids; C032681:desethyloxybutynin; C005419:oxybutynin